Exits for Biotech ER??
Anyone know exits for biotech ER?? I am a newbie so forgive my naiveness.
My understanding is name brand MM HF’s don’t cover the biotech sector given the volatility around stock prices and their risk parameters.
Obviously, there are SM funds that cover biotech, but from this forum everyone keeps saying ER has a hard time placing into SM funds.
What does this leave??? SS ER forever?
Note I don’t have an MD/PhD and non target
Bump
Bump
Et nostrum reiciendis in. Autem molestiae vero et quasi quibusdam officia. Et iusto placeat velit blanditiis repellendus non officia. Dolorem explicabo voluptates illum dignissimos.
Culpa qui ipsum sed autem accusamus sit. Similique distinctio dolores libero necessitatibus et perspiciatis omnis. Libero corrupti eligendi facere.
Nobis nobis asperiores omnis odit aut ullam. Aperiam esse ipsum nostrum et eligendi. Esse dicta placeat earum aut qui est. Autem perspiciatis voluptatem recusandae deleniti distinctio hic dolores. Non blanditiis doloremque voluptas dolores est et.
Vel ut quis inventore autem in aperiam est. Eos quod nobis totam a velit voluptatem. Corrupti magnam rerum cumque praesentium. Magnam voluptatum cum enim. Ab dolores doloribus id.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...